Authors: GILES FJ SHAH PM TEE GY WANG LX CAVILEZ A SUPANDIMAN I RANA F RAPOPORT BL FAHED Z AZIZ Z SUHARTI C CHEN YC TAN P SALIM KA KOCHUPILLAI V GONZAGA M ALI NM ADVANI SH PATEL M CHEN S TORRES R TAM J LYNOTT AM LIM SW FUERST MP KUSUANCO DA POOVALINGAM V

Citation: Fj. Giles et al., ADVERSE-EFFECTS OF ALPHA-2B INTERFERON (IFN) IN PATIENTS WITH PH-PHASE CHRONIC MYELOGENOUS LEUKEMIA ENROLLED IN THE INTERNATIONAL ONCOLOGY STUDY-GROUP (IOSG) CML1 STUDY( EARLY CHRONIC), British Journal of Haematology, 102(1), 1998, pp. 184-184

Authors: GILES FJ KUSUANCO D LYNOTT A SHAH PM WANG LX SUPANDIMAN I POOVALINGAM V RANA F AZIZ F CHEN YC DUTOIT PJ JANUSZEWICZ H TEE GY WOLF M SUMANTRI R ALOMARI K TIAN D BEZWODA WR ABDI E GONZAGA M FAHED F FOURIE LS RUFF P POOL R KIM HC PARIKH PM KIM KY HO BS TAN P LEE SN TIEN SL WIJONO A LOBERIZA S LEE GH KIM SY HO CH BAYLON H AHN MJ THOMAS M WOLF M TIEN HF AYDOGDU I TAM J LIM SW CAVILEZ A

Citation: Fj. Giles et al., PROGNOSTIC FACTORS IN PATIENTS WITH PH-PHASE CHRONIC MYELOGENOUS LEUKEMIA (CML) ENROLLED IN THE INTERNATIONAL ONCOLOGY STUDY-GROUP (IOSG) CML1 STUDY( EARLY CHRONIC), British Journal of Haematology, 102(1), 1998, pp. 187-187